Generation of the human induced pluripotent stem cell line (IBKMOLi002-A) from PBMCs of a patient carrying the heterozygous L271H mutation of the voltage-gated calcium channel subunit Ca(v)1.3-encoding CACNA1D gene

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Tisch, Marcel
- Suarez-Cubero, Marta
- Fauth, Christine
- Defrancesco, Michaela
- Zschocke, Johannes
- Gunther, Katharina
- Edenhofer, Frank
Abstract
Congenital hyperinsulinemic hypoglycemia (HH) is the most frequent cause of persistent and recurrent hypoglycemia. Peripheral mononuclear blood cells (PBMCs) from a patient diagnosed with HH, alongside autism-spectrum-disorder (ASD), carrying a heterozygous c.812 T > A (L271H) mutation in the voltage-gated calcium channel subunit Cav1.3-encoding gene CACNA1D, were reprogrammed into induced pluripotent stem cells (iPSC). The CACNA1D L271H iPSC (IBKMOLi002-A) exhibit a normal karyotype, high expression of pluripotency-associated markers and the capacity to differentiate into cells of all three germ layers. We provide a novel patient-specific iPSC line, allowing to study HH, ASD, the associated neurodevelopmental disorder as well as CACNA1D-associated channelopathies in general.
Copyright © 2022. Published by Elsevier B.V.
Datos de la publicación
- ISSN/ISSNe:
- 1873-5061, 1876-7753
- Tipo:
- Article
- Páginas:
- 102784-102784
- Factor de Impacto:
- 0,482 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
STEM CELL RESEARCH ELSEVIER SCIENCE BV
Documentos
- No hay documentos
Filiaciones
Proyectos asociados
VIGILANCIA POSTCOMERCIALIZACIÓN PARA CONTROLAR LA SEGURIDAD Y LA EFICACIA A LARGO PLAZO DE OMNITROPE® EN NIÑOS Y ADOLESCENTES (PATRO CHILDREN).
Investigador Principal: FRANCISCA MORENO MACIÁN
SAN-SOM-2011-01 . 2012
BASE DE DATOS DEL FORO EUROPEO DE INCRELEX® (MECASERMINA [DERIVADA DEL ADNR] INYECTABLE) EN EL RETRASO DEL CRECIMIENTO: REGISTRO DE PACIENTES EUROPEOS PARA VIGILAR LA EFICACIA Y LA SEGURIDAD A LARGO PLAZO DE INCRELEX®.
Investigador Principal: FRANCISCA MORENO MACIÁN
IPS-MEC-2008-01 . 2016
RELACIÓN ENTRE ADHERENCIA AL TRATAMIENTO CON GH Y CRECIMIENTO LONGITUDINAL.
Investigador Principal: MARIA CARMEN DE MINGO ALEMANY
HLF-SOM-2019-01 . 2019
ESTUDIO PROSPECTIVO, ALEATORIZADO Y CON ENMASCARAMIENTO DOBLE, EN EL QUE SE COMPARA LY900014 CON HUMALOG, CON UN GRUPO EN EL QUE SE ADMINISTRA LY900014 POSPRANDIAL SIN ENMASCARAMIENTO, EN NIÑOS Y ADOLESCENTES CON DIABETES DE TIPO 1: PRONTO-PEDS
Investigador Principal: FRANCISCA MORENO MACIÁN
I8B-MC-ITSB . 2020
Cita
Tisch M,De Mingo MC,Suarez M,Fauth C,Defrancesco M,Zschocke J,Gunther K,Edenhofer F. <p>Generation of the human induced pluripotent stem cell line (IBKMOLi002-A) from PBMCs of a patient carrying the heterozygous L271H mutation of the voltage-gated calcium channel subunit Ca(v)1.3-encoding CACNA1D gene</p>. Stem Cell Res. 2022. 61. p. 102784-102784. IF:1,200. (4).